About NVision
NVision Imaging Technologies GmbH was founded in 2015 with a vision to revolutionize medical imaging through quantum technology. What started as a small startup has grown into a key player in the field of Magnetic Resonance Imaging (MRI), aiming to enhance the accuracy and speed of cancer diagnosis and treatment assessment. Leveraging quantum physics advancements, NVision has developed innovative solutions that transform existing MRI systems into high-performance metabolic imagers.
At the core of NVision's technology is its POLARIS hyperpolarization device, which enables healthcare providers to measure cellular metabolism with unprecedented speed and precision. This groundbreaking technology allows for the early detection of treatment responses, thus aiding clinicians in making informed decisions about patient care. With applications spanning oncology, cardiology, and beyond, NVision is focused on improving current diagnostic methods and developing new ones to facilitate more effective patient management.
FAQs
- Which countries does NVision have remote employees in?
- NVision has employees in Germany.
- When was NVision founded?
- NVision was founded in 2015.
- Who is the CEO of NVision?
- The CEOs of NVision are Sella Brosh, M.D..
- How many employees does NVision have?
- NVision has 51-200 employees.
- What industries or markets does NVision operate in?
- NVision operates in the following markets: Medical Imaging, Quantum Technology, Magnetic Resonance Imaging (MRI), Healthcare Technology, Cardiology Diagnostics, Medical Devices, Cancer Treatment Assessment, Metabolic Imaging, Clinical Diagnostics, and Cancer Diagnostics.
- What is NVision's website?
- NVision's website is nvision-imaging.com.